Boston Scientific's Alair asthma treatment gets a thumbs-up | Regulatory Roundup

March 29, 2012 by MassDevice staff

Boston Scientific's Alair asthma system gets the OK from CTAF; FDA warns Lucero Medical on Enduramesh manufacturing and IntelliCell Biosciences on marketing of aesthetic stem cell treatment; FDA releases final guidance on benefit-risk determinations; and more. Regulatory Roundup

 BSX's Alair asthma system gets the OK from CTAF

Get the complete picture with a MassDevice Plus membership. Registered users can login here.


Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp